Company Filing History:
4 out of 2,623 
1 out of 3,923 
Years Active: 2017-2024
Title: **Sonia Guedan Carrio: Innovator in Cancer Immunotherapy**
Introduction
Sonia Guedan Carrio, based in Philadelphia, PA, is a prominent inventor in the field of cancer treatment. With four patents to her name, she has made significant contributions toward advancing immunotherapy techniques to fight cancer. Her innovative approaches focus on utilizing genetically modified T cells, enhancing their efficacy in targeting cancer cells.
Latest Patents
Sonia's recent patents include groundbreaking inventions that leverage ICOS-based therapies for cancer treatment. The first patent details the use of ICOS-based cars to enhance antitumor activity and car persistence. This invention involves administering genetically modified Th17 cells that express a CAR (Chimeric Antigen Receptor) with specific components aimed at treating cancer in humans.
Another of her notable patents is focused on CD28 compositions and methods for chimeric antigen receptor therapy. This invention outlines compositions and methods for effectively treating diseases associated with cancer-associated antigens. It describes CARs that target specific cancer-associated antigens and includes innovative methods for administering genetically modified T cells that express these CARs, potentially incorporating a mutant CD28 costimulatory domain for improved effectiveness.
Career Highlights
Sonia has established a notable career in the biomedical field. She has worked at esteemed organizations such as the University of Pennsylvania and Novartis AG, where she developed her innovative ideas and conducted extensive research in cancer immunotherapy.
Collaborations
Throughout her career, Sonia has collaborated with esteemed colleagues, including Carl H. June and Yangbing Zhao. Together, they have pushed the boundaries of cancer research, contributing to significant advancements in the treatment of various cancers through innovative techniques in immunotherapy.
Conclusion
Sonia Guedan Carrio exemplifies the role of innovation in medicine, particularly in the fight against cancer. Her patents represent vital steps forward in developing effective immunotherapies, showcasing her commitment to improving patient outcomes. As she continues her work, her contributions are bound to inspire further advancements in cancer treatment and beyond.